Perth, Australia (ABN Newswire) - MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) ("MMJ") is pleased to attach a copy of a news release by MediPharm Labs Inc ("MediPharm Labs") (CVE:LABS) (OTCMKTS:MLCPF) announcing that it has entered into a multi-year cannabis extraction agreement with TerrAscend Corp. (CNSX:TER) (OTCMKTS:TRSSF) ("TerrAscend").
MMJ owns approximately 4.4 million shares for a 4.5% shareholding (at a cost of CAD$0.85 per share) and 2.9 million warrants (exercisable at CAD$1.20 per share by October 2020) in MediPharm Labs.
To view the news release, please visit:
http://abnnewswire.net/lnk/8R6HHUPS
MMJ owns approximately 4.4 million shares for a 4.5% shareholding (at a cost of CAD$0.85 per share) and 2.9 million warrants (exercisable at CAD$1.20 per share by October 2020) in MediPharm Labs.
To view the news release, please visit:
http://abnnewswire.net/lnk/8R6HHUPS
About MMJ Group Holdings Ltd:
MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: http://www.mmjphytotech.com.au/investors/
Source:
MMJ Group Holdings Ltd
Contact:
Investor and Media Enquiries: Jason Conroy Chief Executive Officer T: +61-2-8098-0819 E: [email protected]